D-1241-2019 Class III Terminated

Recalled by Akorn Inc — Lake Forest, IL

FDA drug recall D-1241-2019 was initiated by Akorn Inc on Apr 23, 2019 and is designated Class III. Reason for recall: Failed impurities/degradation specification: Out of Specification result for total impurity at 4.0% (Limit: NMT 3.0%) at 12 months stability testing. The recall status is terminated (terminated Jul 28, 2022). Affected quantity: 5,380 cartons (25 ampules per carton).

Recall details

Product Type
Drugs
Report Date
May 1, 2019
Initiation Date
Apr 23, 2019
Termination Date
Jul 28, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
5,380 cartons (25 ampules per carton)

Product description

Fentanyl Citrate Injection, USP, 100 mcg/2 mL (50 mcg/mL), 25 Ampules per carton, (2 mL each), Rx only, Manufactured by: Akorn, Inc., Lake Forest, IL 60045, NDC 17478-030-25

Reason for recall

Failed impurities/degradation specification: Out of Specification result for total impurity at 4.0% (Limit: NMT 3.0%) at 12 months stability testing.

Distribution pattern

U.S.A. Nationwide

Code information

Lot #: 011198, Exp 01/22

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1241-2019
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1241-2019. Report a data issue: hello@regdatalab.com.